Ross Lindsay

Ross Lindsay is a seasoned research and development professional with extensive experience in immunology, particularly in the areas of cancer vaccines and HIV vaccine development. Currently serving as Senior Director of R&D at Stemline Therapeutics, Inc., Ross Lindsay is responsible for the identification, negotiation, and management of CROs and academic alliances, as well as overseeing the development of pharmacokinetic and immunoassays. Prior roles include positions as Principal Scientist II at the International AIDS Vaccine Initiative, where Ross Lindsay conducted comparative assessments of adaptive immune responses and developed in vitro assays, and as a Postdoctoral Fellow at the National Institutes of Health, focusing on in vivo vaccine development. Educational credentials include a PhD in Immunology from UCL and an MSci in Microbiology from the University of Glasgow.